190 likes | 307 Views
NBSTRN SCID National Call February 24, 2012. Call in number: 1-866-671-5988 Conference code: 841-900-2082. Agenda. New agenda items. Standing Agenda – Led by Dr. Michele Caggana Introduction of New Participants Update from States Update from States that are Currently Screening
E N D
NBSTRN SCID National CallFebruary 24, 2012 Call in number: 1-866-671-5988 Conference code: 841-900-2082
Agenda New agenda items • Standing Agenda – Led by Dr. Michele Caggana • Introduction of New Participants • Update from States • Update from States that are Currently Screening • Update from States that are not Currently Screening • Update on R4S Portal – Roshini and Fred • Update from CDC • NSQAP TREC PT Program – Joanne (not on call today) • NSTRI - Bob • Update on Educational Efforts • PIDTC Request • Implementation Issues • Florida Whitepaper - Heather • Florida Issues - Heather • Long-Term Follow-Up Effort - Amy Newborn Screening Translational Research Network
January 2012 Update Newborn Screening Translational Research Network
Percentage of Annual Births Newborn Screening Translational Research Network
January 2012 Update From States • States Currently Screening • CA – Began Aug 2010; ~700,000 screened. • CT – Validation completed in October. First transplant last week. • MI – Began Oct 1st 2011; ~30,000 screened. No cases. • States Not Currently Screening • VA – Working on cost estimates to build out facility. Looking into several funding options. Practicing with molecular methods. • FL – Governor did not approve portion of budget that included SCID. Another opportunity to resubmit in the near future. • NE – Probably won’t begin screening until 2013. • WA – Advisory committee meeting delayed. Update at next call. • MI – Plan to implement in mid 2013. • Industry • No Update Newborn Screening Translational Research Network
January 2012 R4S Update • SCID module available. Roshini Abraham and Fred Lorey are the co-curators. • Contact David McHugh to access - McHugh.David@mayo.edu • Goal is to get states that are screening and/or planning to screen to actively enter data. Pilot data can be entered into R4S. • Introductory webinar can be held at any time. • Currently 6 condition types • Depends on diagnosis given by immunologist Newborn Screening Translational Research Network
January 2012 R4S Update • Introductory webinar can be held at any time. • Currently 6 condition types • Depends on diagnosis given by immunologist • Goal is to get states that are screening and/or planning to screen to actively enter data. • Pilot data can be entered into R4S. Newborn Screening Translational Research Network
R4S Documentation Newborn Screening Translational Research Network
January 2012 CDC Update - Bob • Development of CLSI Guidance in process. • Development of a calibrator in process. • 15 labs participating – 2 foreign • Open to any lab • Collaborating with J Puck and A Comeau Newborn Screening Translational Research Network
January 2012 CDC Update - JoAnne • Formal proficiency program in place. • 8 laboratories enrolled. • Quarterly proficiency testing. • Currently recording first TREC report. • Available throughout the US in 2012. • Plan to introduce internationally in 2013. • 2nd panel now accepting and waiting for results. • Everyone is doing really well. Newborn Screening Translational Research Network
PIDTC • PIDTC is part of the NIH funded Rare Diseases Clinical Research Network • Working to improve the outcome of patients with SCID • NBSTRN discussed potential collaborative efforts between the PIDTC and Rare Diseases Clinical Research Network Data Management and Coordinating Center (RDCRN DMCC) • Goal is to avoid duplication of efforts and work together Newborn Screening Translational Research Network
PIDTC Scientific Workshop • 2nd annual PIDTC Scientific Workshop to be held in Boston April 26-28th, 2012 • In preparation for the workshop, Dr. Jennifer Puck has asked for help in collecting information on SCID NBS screening, diagnosis, treatment and health outcomes • Only for states currently screening • Some information from screening lab and some from clinicians • Identify immunologists/transplanters who would have the most up to date outcomes • NBSTRN staff will help collect the information – contact Amy Brower • Worksheet sent out to group – review information on the next two slides Newborn Screening Translational Research Network
Information for PIDTC Meeting Date NBS started: _______. Number screened: __________. Statewide? Y/N ___. % with 1st test not normal so that any 2nd specimen needed (positives + not definitive): ________. Number of infants requiring lymphocyte subsets by flow: _________; this is ___ % of total screened. Number of infants with <1500 T cells : _______; this is ___ % of total screened. Number of typical SCID (<300 autologous T cells, PHA <10% of control): ______. Genotypes, number of each: _________________________________________. Number of leaky SCID/Omenn(300-1500 autologous T cells, no maternal cells, PHA 10-30%): ______. Genotypes, number of each: _______________________. Number of variant SCID (300-1500 autologous T cells with impaired function, no maternal cells, no genotype found): ______. Number of syndromes with low T cells (DiGeorge, CHARGE, CHH, etc): _____. Number of secondary low T cells (heart disease, third spacing, etc): _____. Newborn Screening Translational Research Network
Information for PIDTC Meeting Treatment of infants identified with SCID by NBS
January Discussion of Implementation Issues • Cost • Heather Smith from Florida is collecting cost estimates. Please email her your information directly. • Equipment • Lucy/Iowa is looking for thoughts on purchasing equipment. Please email her your thoughts. • Screening and short-term follow-up algorithms • Materials shared to date are on the NBSTRN website Newborn Screening Translational Research Network
January Discussion of Implementation Issues • Educational Efforts • Materials shared to date are on the NBSTRN website • SCID Angels is updating video • Advocacy • The Immune Deficiency Foundation offered itself as a resource for states to identify patient advocates, provide educational materials, and assist with identifying physician experts for follow up. • Please contact Emily Hovermaleehovermale@primaryimmune.org • Jennifer Garcia appointed to the Save Babies Through Screening Foundation Board of Directors – congrats Jennifer!! Newborn Screening Translational Research Network
February Implementation Issues • Heather Smith • Florida Whitepaper • Florida Cost to Screen Newborn Screening Translational Research Network
Long-Term Follow-Up Update • PIDTC shared their data forms and currently comparing data elements • Reviewing USIDNET data sets • Data capture tool development initiated but won’t be completed until we have identified a grantee, investigator or program that wants to use the tool Newborn Screening Translational Research Network
Action Items Newborn Screening Translational Research Network